Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders (2012)
- Authors:
- USP affiliated authors: HALLAK, JAIME EDUARDO CECILIO - FMRP ; ZUARDI, ANTONIO WALDO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP
- Unidade: FMRP
- DOI: 10.1007/s00213-011-2449-3
- Subjects: CANNABIS; FÁRMACOS (EXPERIMENTOS;TESTES); DOENÇAS NEURODEGENERATIVAS
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2012
- Source:
- Título: Psychopharmacology
- ISSN: 0033-3158
- Volume/Número/Paginação/Ano: v. 219, n. 4, p. 1133-1140, 2012
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
FAGHERAZZI, Elen V. et al. Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders. Psychopharmacology, v. 219, n. 4, p. 1133-1140, 2012Tradução . . Disponível em: https://doi.org/10.1007/s00213-011-2449-3. Acesso em: 13 fev. 2026. -
APA
Fagherazzi, E. V., Garcia, V. A., Maurmann, N., Bervanger, T., Halmenschlager, L. H., Busato, S. B., et al. (2012). Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders. Psychopharmacology, 219( 4), 1133-1140. doi:10.1007/s00213-011-2449-3 -
NLM
Fagherazzi EV, Garcia VA, Maurmann N, Bervanger T, Halmenschlager LH, Busato SB, Hallak JEC, Zuardi AW, Crippa JA de S, Schröder N. Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders [Internet]. Psychopharmacology. 2012 ; 219( 4): 1133-1140.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1007/s00213-011-2449-3 -
Vancouver
Fagherazzi EV, Garcia VA, Maurmann N, Bervanger T, Halmenschlager LH, Busato SB, Hallak JEC, Zuardi AW, Crippa JA de S, Schröder N. Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders [Internet]. Psychopharmacology. 2012 ; 219( 4): 1133-1140.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1007/s00213-011-2449-3 - Cannabidiol and neuroprotection: evidence from preclinical studies
- Cannabidiol displays proteomic similarities to antipsychotics in cuprizone-exposed human oligodendrocytic cell line MO3.13
- Marijuana, feijoada and the debate on drug legalization
- Cannabidiol for the treatment of psychosis in Parkinson's disease
- Δ9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol
- Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain
- Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia
- Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system
- Cannabidiol reverses memory impairments and activates components of the Akt/GSK3β pathway in an experimental model of estrogen depletion
- Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy
Informações sobre o DOI: 10.1007/s00213-011-2449-3 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
